Skip to main content
See every side of every news story
Published • loading... • Updated

Ideaya Sets Registrational Trial Strategy for IDE849 for Neuroendocrine Carcinomas

Ideaya plans a 90-patient extension cohort and two Phase 3 trials to seek accelerated and full approval for IDE849.

Summary by Seeking Alpha
Ideaya plans a 90-patient IDE849 extension cohort in GEP-NEC to support accelerated approval, with confirmed response rate as the primary endpoint. Read more here.

6 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources are Center
67% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Billings Gazette broke the news in Billings, United States on Monday, November 16, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal